Table 3.
Adopted therapy in patients with VTE score ≥ 3 (n = 1534).
| Anticoagulation | N | % |
|---|---|---|
| Ambulation | 453 | 29.5 |
| Enoxaparin 20 mg | 30 | 2.0 |
| Enoxaparin 40 mg | 630 | 41.1 |
| Enoxaparin 60 mg | 262 | 17.1 |
| Enoxaparin 80 mg | 45 | 2.9 |
| Others | 114 | 7.4 |
| Total | 1534 | 100 |
| Missing | 92 | 5.7 |
VTE, Venous Thromboembolism.